The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) |
93.310 |
PAR-22-054 |
| Home and Community-Based Physical Activity Interventions to Improve the Health of Wheelchair Users (R01 Clinical Trial Required) |
93.865 |
RFA-HD-22-017 |
| HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional) |
93.213, 93.233, 93.279, 93.307, 93.313, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.867 |
RFA-AT-22-004 |
| Clinical Trial Readiness for Functional Neurological Disorders (U01 Clinical Trial Optional) |
93.853 |
PAR-22-053 |
| HEAL Initiative: Sickle Cell Disease Pain Management Trials Utilizing the Pain Management Effectiveness Research Network Cooperative Agreement (UG3/UH3, Clinical Trial Required) |
93.213, 93.233, 93.279, 93.307, 93.313, 93.350, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.867 |
RFA-AT-22-005 |
| Cellular Senescence Network: Technology Development and Application in Human Systems (UG3/UH3 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-22-004 |
| Cell-Specific Impact of Liquid-Liquid Phase Separation in Aging and AD/ADRD (R21 Clinical Trial Not Allowed) |
93.866 |
RFA-AG-23-002 |
| Cellular Senescence Network: Technology Development and Application in Murine Systems (UG3/UH3 Clinical Trial Not Allowed) |
93.310 |
RFA-RM-22-005 |
| Cellular Senescence Network: Murine Tissue Mapping Centers (U54 - Clinical Trial Not Allowed) |
93.310 |
RFA-RM-22-003 |
| Elucidating the Role of Nutrition in Care and Development of Preterm Infants (R01 Clinical Trial Optional) |
93.865 |
RFA-HD-22-023 |
| Limited Competition: NIH Health Care Systems Research Collaboratory - Coordinating Center (U24 Clinical Trial Not Allowed) |
93.213, 93.233, 93.307, 93.361, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.855, 93.866 |
RFA-AT-22-002 |
| Understanding the Role of Bilingualism in Cognitive Reserve/Resilience in Aging and AD/ADRD (R01 Clinical Trial Optional) |
93.866 |
RFA-AG-23-001 |
| Promoting Reproductive Health for Adolescents and Adults with Disabilities (R01 Clinical Trial Optional) |
93.313, 93.865 |
RFA-HD-23-005 |
| Research Bases for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) |
93.393, 93.395, 93.399 |
RFA-CA-21-046 |
| Coordinating Center for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (U24 Clinical Trial Required) |
93.393, 93.395, 93.399 |
RFA-CA-21-045 |
| Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) |
93.393, 93.395, 93.399 |
RFA-CA-21-047 |
| A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Optional) |
93.395 |
RFA-CA-21-063 |
| Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) |
93.393 |
PAR-22-049 |
| Expanding Differentiated Care Approaches for Adolescents Living with HIV (R34 Clinical Trial Optional) |
93.242 |
RFA-MH-22-106 |
| Identification and Characterization of Persistence Mechanisms of Select Protozoan Pathogens (R01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-21-075 |
| Enhanced Interpersonal Focused Strategies for Suicide Prevention Interventions (R34 Clinical Trial Required) |
93.242 |
RFA-MH-22-125 |
| Clinical Research Education and Career Development (CRECD) Program (R25-Independent Clinical Trial Not Allowed) |
93.121, 93.307, 93.361 |
PAR-21-347 |
| Expanding Differentiated Care Approaches for Adolescents Living with HIV (R01 Clinical Trial Optional) |
93.242 |
RFA-MH-22-105 |
| NIH Blueprint for Neuroscience Research Short Courses in Neurotherapeutics Development (R25 Clinical Trial Not Allowed) |
93.113, 93.121, 93.213, 93.242, 93.273, 93.279, 93.286, 93.853, 93.865, 93.866, 93.867 |
RFA-NS-21-025 |
| Advancing Group A Streptococcus Vaccine Discovery (R01 Clinical Trial Not Allowed) |
93.855 |
RFA-AI-21-070 |
| NIH Health Care Systems Research Collaboratory - Pragmatic and Implementation Trials of Embedded Interventions (UG3/UH3, Clinical Trials Optional) |
93.213, 93.233, 93.307, 93.361, 93.837, 93.838, 93.839, 93.840, 93.846, 93.866 |
RFA-AT-22-001 |
| Diabetes Research Centers (P30 Clinical Trial Optional) |
93.847 |
RFA-DK-21-029 |
| Pelvic Floor Disorders Network (UG1 Clinical Trial Required) |
93.313, 93.865 |
RFA-HD-22-021 |
| Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed) |
93.242 |
PAR-22-038 |
| NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-22-040 |
| Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) |
93.393, 93.399 |
PAR-21-341 |
| Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Not Allowed) |
93.242 |
PAR-22-039 |
| Clinical Relevance of the Linkage between Environmental Toxicant Exposures and Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) |
93.853, 93.866 |
PAR-22-048 |
| Pelvic Floor Disorders Network (U24 Clinical Trial Required) |
93.865 |
RFA-HD-22-022 |
| Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) |
93.172 |
PAR-21-321 |
| NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed) |
93.233, 93.837, 93.838, 93.839, 93.840 |
PAR-22-034 |
| Pilot Practice-based Research for Primary Care Suicide Prevention (R34 Clinical Trial Optional) |
93.242 |
RFA-MH-22-120 |
| IDeA Regional Entrepreneurship Development (I-RED) Program (STTR) (UT2 Clinical Trial Not Allowed) |
93.859 |
RFA-GM-22-001 |
| HEAL Initiative: Advancing Health Equity in Pain Management (R61/R33 Clinical Trial Required) |
93.121, 93.213, 93.242, 93.273, 93.279, 93.307, 93.313, 93.350, 93.361, 93.846, 93.847, 93.853, 93.866, 93.867 |
RFA-NS-22-002 |
| Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER) (R01 Clinical Trial Optional) |
93.113, 93.143 |
RFA-ES-21-007 |
Search Results 1761-1800 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
